issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry
2025 · 4th Quarter (Oct 1 - Dec 31)
ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS
Filed by BROWNSTEIN HYATT FARBER SCHRECK, LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 15, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Filing UUID
- c599c9cc-6b06-4640-b0ac-3c4c489477fc
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Companys expansion of its domestic footprint.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.